Gedeon Richter Sees Profit Jump By 40%
Driven By Strong Vraylar Tailwind As Cariprazine Brand Beats Expectations
A strong tailwind from antipsychotic drug Vraylar helped Hungary’s Gedeon Richter to post a 40% leap in 2019 net profit. Analysts see more upside ahead for eastern Europe’s largest drugmaker.
